Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Implants
Company comments on U.S. FDA action regarding silicone breast implants
September 1st, 2005
INAMED Corporation (IMDC) issued comments on action by the U.S. Food and Drug Administration (FDA) regarding silicone breast implants. The company views the news as positive for the industry, physicians and their patients, even though according to a statement issued by the FDA earlier, "an approvable letter is one of several intermediate steps in the FDA review process of new products." The company remains confident about its recently modified responsive silicone gel implant PMA, currently under FDA review, which is comparable to the competitor's in terms of safety and effectiveness. Additionally, the development has positive...
Source: Women's Health Weekly (2005-09-01)
|
